Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation (Q37975121)

26 August 2017

title

Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation (English)

1 reference

26 August 2017

0 references

0 references

Christos A Goudis

1

1 reference

26 August 2017

Eleftherios M Kallergis

series ordinal

2

1 reference

26 August 2017

Panos E Vardas

series ordinal

3

1 reference

26 August 2017

language of work or name

1 reference

10 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

14

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

623-630

1 reference

Mortality as an endpoint in atrial fibrillation

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Electrical, contractile and structural remodeling during atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

New ideas about atrial fibrillation 50 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Atrial fibrillation and heart failure: natural history and pharmacological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

The role of the renin-angiotensin system in the development of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Induction of cardiac fibrosis by transforming growth factor-beta(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

The role of TGF-beta signaling in myocardial infarction and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Activation of valvular interstitial cells is mediated by transforming growth factor-beta1 interactions with matrix molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

The CCN family of angiogenic regulators: the integrin connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Global gene expression profiling in the failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Tachycardia of atrial myocytes induces collagen expression in atrial fibroblasts through transforming growth factor β1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Rac1 and connective tissue growth factor. The missing link between atrial remodeling and the pathogenesis of atrial fibrillation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Mast cells in the promotion and limitation of chronic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Differential release of mast cell mediators and the pathogenesis of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Collagen expression in mechanically stimulated cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

The role of atrial dilatation in the domestication of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Histological substrate of atrial biopsies in patients with lone atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Information learned from animal models of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Inflammation as a risk factor for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

The role of connexin40 in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

NAD(P)H oxidase: role in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Gene expression profiling of oxidative stress on atrial fibrillation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Oxidative stress on pulmonary vein and left atrium arrhythmogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Regulation of collagen degradation in the rat myocardium after infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Matrix metalloproteinase-9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin-converting enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Contrasting gene expression profiles in two canine models of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Pathophysiology and prevention of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Post-operative atrial fibrillation: a maze of mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR398

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUR398

1 reference

26 August 2017

1 reference